Canadian Lung Association

Last updated

The Canadian Lung Association (CLA; French : Association pulmonaire du Canada) is a national organization and volunteer-based health charity that supports lung health research, education, prevention of disease/disorders and advocacy in Canada.

Contents

Beginning as a movement in 1900 to control the spread of tuberculosis (TB) and provide better services for TB patients, the CLA today focuses on a range of pulmonary-related issues and concerns. This includes leading initiatives to promote pulmonary health and help prevent lung disease. [1]

About

The CLA works at the national, provincial, and community levels to improve and promote lung health. Its focus is primarily on chronic lung diseases like asthma and COPD, infectious diseases like TB, flu, and pneumonia, and breathing disorders like sleep apnea, cystic fibrosis, and lung cancer. They provide information to both citizens and governments and advocate for improved care for lung disease patients.

To prevent lung diseases, the CLA conducts numerous initiatives including programs to inform people about the effects of air pollution and tobacco use. This includes providing help to smokers who are trying to quit, and providing educational material and programs to reduce the number of people who take up smoking. Transportation, radon and wood smoke issues are the subjects of CLA education and advocacy efforts. They also encourage governments at every level to create regulations, laws and policies that strengthen societal lung health in Canada in general.

The CLA funds medical research in Canada to find treatments and cures for lung diseases, primarily through the Canadian Thoracic Society and Canadian Respiratory Health Professionals. They assist doctors and allied health professionals in setting and maintaining the highest standards in patient care, and to develop and convey new knowledge about lung diseases and treatments. The CLA's medical journal, produced in collaboration with the Canadian Thoracic Society, is the quarterly Canadian Respiratory Journal.

In 2020, the Ontario Lung Association ended its partnership with the Canadian Lung Association and renamed itself the Lung Health Foundation. [2] In late 2021, the CLA said that additional provincial groups had ended their relationship with the national body, and that it was undertaking a review of its operating model. [3] The BC Lung Association (now the BC Lung Foundation) and Alberta Lung have confirmed that they are no longer associated with the CLA, while Lung Saskatchewan has similarly rebranded. [4] [5] [6]

Programs and services

The Lung Association offers various programs and services through its national and provincial offices.

The national office, located in Ottawa, supports the work of the provincial associations. In addition, the national office coordinates national fundraising activities, including the annual Christmas Seal Campaign. It also supports national lung health programs like Breathworks for those with COPD. Apart from that, it delivers online lung health information and also leads advocacy campaigns at the federal government level. Managing a national research program is also a service offered by the Lung Association.

The provincial organizations, working in every province and territory, deliver lung health services and programs through their local offices and volunteer networks. Provincial Lung Associations offer a variety of programs, which include presentations and teaching materials on lung health topics, quit lines to help smokers overcome their addiction; and support groups for people living with lung diseases, which help them to build their moral support. Apart from that, it provides information about lung diseases, treatments, and how to cope. The CLA also organizes local fundraising activities, and has good expertise and advocacy on provincial lung health issues. The Canadian Lung Association carries out professional development and training for lung health professionals.

A close connection between The Lung Association and the Governor General of Canada goes back to 1900, when the 8th Governor General of Canada—the Earl of Minto—helped found the Canadian Tuberculosis Association (as The Lung Association was originally known) at a meeting at Rideau Hall.

Research

The CLA funds medical research in Canada to find treatments and cures for lung disease and to better understand lung function and physiology and the causes of lung disease. All research funded by the CLA and the provincial Lung Associations is subjected to peer review.

See also

Related Research Articles

<span class="mw-page-title-main">Tuberculosis</span> Infectious disease

Tuberculosis (TB) is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs, but it can also affect other parts of the body. Most infections show no symptoms, in which case it is known as latent tuberculosis. Around 10% of latent infections progress to active disease which, if left untreated, kill about half of those affected. Typical symptoms of active TB are chronic cough with blood-containing mucus, fever, night sweats, and weight loss. It was historically referred to as consumption due to the weight loss associated with the disease. Infection of other organs can cause a wide range of symptoms.

<span class="mw-page-title-main">Respiratory therapist</span> Practitioner in cardio-pulmonary medicine

A respiratory therapist is a specialized healthcare practitioner trained in critical care and cardio-pulmonary medicine in order to work therapeutically with people who have acute critical conditions, cardiac and pulmonary disease. Respiratory therapists sometimes graduate from a college or university with a degree in respiratory therapy and have passed a national board certifying examination. The NBRC is responsible for credentialing as a CRT, or RRT,

<span class="mw-page-title-main">Pulmonology</span> Study of respiratory diseases

Pulmonology, pneumology or pneumonology is a medical specialty that deals with diseases involving the respiratory tract. It is also known as respirology, respiratory medicine, or chest medicine in some countries and areas.

Nontuberculous mycobacteria (NTM), also known as environmental mycobacteria, atypical mycobacteria and mycobacteria other than tuberculosis (MOTT), are mycobacteria which do not cause tuberculosis or leprosy. NTM do cause pulmonary diseases that resemble tuberculosis. Mycobacteriosis is any of these illnesses, usually meant to exclude tuberculosis. They occur in many animals, including humans and are commonly found in soil and water.

<span class="mw-page-title-main">Tuberculosis management</span>

Tuberculosis management describes the techniques and procedures utilized for treating tuberculosis (TB).

<span class="mw-page-title-main">Respiratory disease</span> Disease of the respiratory system

Respiratory diseases, or lung diseases, are pathological conditions affecting the organs and tissues that make gas exchange difficult in air-breathing animals. They include conditions of the respiratory tract including the trachea, bronchi, bronchioles, alveoli, pleurae, pleural cavity, the nerves and muscles of respiration. Respiratory diseases range from mild and self-limiting, such as the common cold, influenza, and pharyngitis to life-threatening diseases such as bacterial pneumonia, pulmonary embolism, tuberculosis, acute asthma, lung cancer, and severe acute respiratory syndromes, such as COVID-19. Respiratory diseases can be classified in many different ways, including by the organ or tissue involved, by the type and pattern of associated signs and symptoms, or by the cause of the disease.

<span class="mw-page-title-main">Vancouver General Hospital</span> Hospital in British Columbia, Canada

Vancouver General Hospital is a medical facility located in Vancouver, British Columbia. It is the largest facility in the Vancouver Hospital and Health Sciences Centre (VHHSC) group of medical facilities. VGH is Canada's third largest hospital by bed count, after Hamilton General Hospital, and Foothills Medical Centre.

<span class="mw-page-title-main">Royal Papworth Hospital</span> Hospital in England

Royal Papworth Hospital is a specialist heart and lung hospital, located on the Cambridge Biomedical Campus in Cambridgeshire, England. The Hospital is run by Royal Papworth Hospital NHS Foundation Trust.

The American Thoracic Society (ATS) is a nonprofit organization focused on improving care for pulmonary diseases, critical illnesses and sleep-related breathing disorders. It was established in 1905 as the

<span class="mw-page-title-main">Bronchitis</span> Inflammation of the large airways in the lungs

Bronchitis is inflammation of the bronchi in the lungs that causes coughing. Bronchitis usually begins as an infection in the nose, ears, throat, or sinuses. The infection then makes its way down to the bronchi. Symptoms include coughing up sputum, wheezing, shortness of breath, and chest pain. Bronchitis can be acute or chronic.

Respiratory Health Association is a nonprofit organization located on Chicago's Near West Side.

Pulmonary rehabilitation, also known as respiratory rehabilitation, is an important part of the management and health maintenance of people with chronic respiratory disease who remain symptomatic or continue to have decreased function despite standard medical treatment. It is a broad therapeutic concept. It is defined by the American Thoracic Society and the European Respiratory Society as an evidence-based, multidisciplinary, and comprehensive intervention for patients with chronic respiratory diseases who are symptomatic and often have decreased daily life activities. In general, pulmonary rehabilitation refers to a series of services that are administered to patients of respiratory disease and their families, typically to attempt to improve the quality of life for the patient. Pulmonary rehabilitation may be carried out in a variety of settings, depending on the patient's needs, and may or may not include pharmacologic intervention.

TB Alert is a charity working to raise awareness about and support effective treatment of the disease tuberculosis in the UK and internationally. It was registered in 1998 and launched on World Tuberculosis Day in 1999 in response to the resurgence of tuberculosis (TB) in the UK and worldwide. It is headquartered in Brighton.

<span class="mw-page-title-main">Chronic obstructive pulmonary disease</span> Lung disease involving long-term poor airflow

Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by long-term respiratory symptoms and airflow limitation. The main symptoms of COPD include shortness of breath and a cough, which may or may not produce mucus. COPD progressively worsens, with everyday activities such as walking or dressing becoming difficult. While COPD is incurable, it is preventable and treatable. The two most common types of COPD are emphysema and chronic bronchitis and have been the two classic COPD phenotypes. Emphysema is defined as enlarged airspaces (alveoli) whose walls have broken down resulting in permanent damage to the lung tissue. Chronic bronchitis is defined as a productive cough that is present for at least three months each year for two years. Both of these conditions can exist without airflow limitation when they are not classed as COPD. Emphysema is just one of the structural abnormalities that can limit airflow and can exist without airflow limitation in a significant number of people. Chronic bronchitis does not always result in airflow limitation but in young adults who smoke the risk of developing COPD is high. Many definitions of COPD in the past included emphysema and chronic bronchitis, but these have never been included in GOLD report definitions. Emphysema and chronic bronchitis remain the predominant phenotypes of COPD but there is often overlap between them and a number of other phenotypes have also been described. COPD and asthma may coexist and converge in some individuals. COPD is associated with low-grade systemic inflammation.

Canadian Thoracic Society (CTS) is a national not-for-profit medical association representing researchers and healthcare professionals in the field of respirology. It was established when the Canadian Tuberculosis Association, now The Lung Association, recognized the need for a medical association as evidenced by the increase in attendance of both medical and non-medical members at the annual meetings.

<span class="mw-page-title-main">Tuberculosis in India</span> Health issue in India

Tuberculosis in India is a major health problem, causing about 220,000 deaths every year. In 2020, the Indian government made statements to eliminate tuberculosis from the country by 2025 through its National TB Elimination Program. Interventions in this program include major investment in health care, providing supplemental nutrition credit through the Nikshay Poshan Yojana, organizing a national epidemiological survey for tuberculosis, and organizing a national campaign to tie together the Indian government and private health infrastructure for the goal of eliminating the disease.

The Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin is the largest and oldest medical professional organization for respiratory disorders in the German-speaking world and serves as a forum for all medical practitioners and scientists in the field of respiratory medicine. Almost 28% of the more than 3,000 members are women. Pneumologie has been the official journal of the German Respiratory Society since 1981.

<span class="mw-page-title-main">Emphysema</span> Medical condition

Emphysema is any air-filled enlargement in the body's tissues. Most commonly emphysema refers to the enlargement of air spaces (alveoli) in the lungs, and is also known as pulmonary emphysema.

<span class="mw-page-title-main">William N. Rom</span> Sol and Judith Professor of Medicine and Environmental Medicine

William N. Rom is the Sol and Judith Bergstein Professor of Medicine and Environmental Medicine, Emeritus at New York University School of Medicine and former Director of the Division of Pulmonary, Critical Care and Sleep Medicine at New York University and Chief of the Chest Service at Bellevue Hospital Center, 1989–2014. He is Research Scientist at the School of Global Public Health at New York University and Adjunct Professor at the NYU Robert F. Wagner Graduate School of Public Service. He teaches Climate Change and Global Public Health and Environmental Health in a Global World.

<span class="mw-page-title-main">John W. Walsh</span> American NGO leader and patient advocate, 1949–2017

John W. Walsh was an American non-profit leader and patient advocate. After being diagnosed with alpha-1 antitrypsin deficiency, he co-founded the Alpha-1 Foundation and AlphaNet, both of which serve people diagnosed with that condition, and the COPD Foundation, which serves people with chronic obstructive pulmonary disease. As an advocate for alpha-1 and COPD patients, Walsh lobbied before Congress for increased research funding and medical benefits for patients, and served on a number of health-related committees and organizations.

References

  1. "About Us". the lung association. 2014-08-21. Retrieved 2021-10-20.
  2. "Response: Ontario Lung Association Departure". Canadian Lung Association. 2020-01-06.
  3. "CLA Organizational Changes". Canadian Lung Association. November 5, 2021. Retrieved February 11, 2022.
  4. "BC Lung focuses inwards to bring better lung health to British Columbians". BC Lung Foundation. November 1, 2021. Retrieved November 6, 2021.
  5. "Alberta Lung" . Retrieved February 11, 2022. We are no longer affiliated with the Canadian Lung Association.
  6. "Mission, Vision, Impact and Values". The Lung Association of Saskatchewan Inc. Retrieved February 11, 2022.